Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 181 to 195 of 489 results for 2011

  1. Information needs for children and young people:- during their care pathway to diagnosis of food allergy:- What do children and young people with IgE-mediated food allergy and their parents or carers want to know during the process of diagnosis and how is this demand best met?

    assessment and diagnosis Number CG116 Date issued February 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  2. NICE encourages further research into extracorporeal shockwave therapy (ESWT) for refractory greater trochanteric pain syndrome. Research studies should clearly describe patient selection, imaging, and treatment protocols. Outcomes should include functional and quality-of-life scores with at least 1 year of follow-up.

    trochanteric pain syndrome Number IPG376 Date issued January 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  3. For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention, what is the clinical effectiveness of physical activity compared with waiting-list control?

    adults: management Number CG113 Date issued January 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  4. Epiretinal brachytherapy for wet age-related macular degeneration (AMD) should only be used in the context of research. Research studies should address whether epiretinal brachytherapy reduces the progression of wet AMD and whether it can reduce the number of injections of antivascular endothelial growth factor agents (anti-VEGF) required. Long-term outcomes should be reported.

    macular degeneration Number IPG415 Date issued December 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  5. Improving rates of identification and referral of potential donors:- What are the key components of an intervention to improve identification and referral rates?

    deceased organ donation Number CG135 Date issued December 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  6. Further research into endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence should clearly define the patient groups being treated. It should also report the clinical impact in terms of quality of life and long-term outcomes. NICE may review the procedure on publication of further evidence.

    for faecal incontinence Number IPG393 Date issued May 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  7. Further research studies into deep brain stimulation (DBS) for intractable trigeminal autonomic cephalalgias (TACs) should clearly define patient selection and report the intensity and duration of stimulation, medication use and quality of life, in addition to documenting the effects on headache symptoms as clearly as possible.

    autonomic cephalalgias Number IPG381 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  8. Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema (MIB144)

    NICE has developed a medtech innovation briefing (MIB) on Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema .

    Medtech innovation briefing
    Published
    24 April 2018

  9. Mobi-C for cervical disc replacement (MIB70)

    NICE has developed a medtech innovation briefing (MIB) on Mobi-C for cervical disc replacement

    Medtech innovation briefing
    Published
    28 June 2016

  10. eXroid for internal haemorrhoids (MIB201)

    NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids .

    Medtech innovation briefing
    Published
    10 December 2019

  11. Natural history of progression to colorectal cancer in people at increased risk:- What is the natural history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas?

    Crohn's disease or adenomas Number CG118 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  12. Effectiveness of biomarkers for determining level of risk of colorectal cancer:- Which biomarkers, including epigenic and genetic markers, are predictors of colorectal cancer? How should these be used to improve risk stratification?

    Crohn's disease or adenomas Number CG118 Date issued March 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  13. Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens (TA423)

    Evidence-based recommendations on eribulin (Halaven) for locally advanced or metastatic (secondary) breast cancer in adults who have had 2 or more courses of chemotherapy.

    Technology appraisal guidance
    Published
    21 December 2016
    View recommendations

    Sections for TA423

  14. Imaging in the diagnostic pathway for women with ovarian cancer:- Large multicentre case–control studies should be conducted to compare the accuracy of CT versus MRI for staging and for predicting optimal cytoreduction in women with ovarian cancer.

    and initial management Number CG122 Date issued April 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015

  15. Further research into percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices should take the form of well-conducted trials, which should define patient selection, treatment protocols and location and types of arterial lesions treated, and report long-term patency outcomes. NICE may review this procedure on publication of further evidence.

    excision devices Number IPG380 Date issued February 2011 Other details Is this a recommendation for the use

    Research recommendation
    Published
    9 June 2015